Andrew Cameron is an assistant professor of surgery in the Comprehensive Transplant Center. He attended Johns Hopkins Medical School and trained in surgery at the Massachusetts General Hospital in Boston. He pursued fellowship training at UCLA, studying liver transplantation, and now focuses on hepatobiliary surgery. His clinical interests include end stage liver disease and hepatocellular cancer. Cameron runs a basic science laboratory studying molecular aspects of hepatitis C, focusing on developing RNA technology to design novel drugs for prevention of viral recurrence after liver transplant.